This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Younes Anini: Innovator in Obesity Treatment
Introduction
Younes Anini is a notable inventor based in Halifax, Canada. He has made significant contributions to the field of obesity treatment through his innovative research and patented inventions. His work focuses on the mechanisms of ghrelin and its receptor, which play a crucial role in regulating body weight and metabolism.
Latest Patents
Younes Anini holds a patent for a groundbreaking invention titled "Growth hormone secretagogue receptor based protein." This invention revolves around ghrelin, a peptide hormone that binds to the growth hormone secretagogue receptor 1a (GHS-R1a). Ghrelin is known to promote adiposity and obesity in mammals. Anini's patent introduces a soluble decoy GHS-R1a receptor that binds to ghrelin in the periphery, preventing it from interacting with GHS-R1 on cells. This innovative approach aims to antagonize ghrelin, providing a potential therapeutic intervention for obesity-related diseases and cancer. The GHS-R1a receptor is a transmembrane protein that consists of an N-terminal extracellular domain, seven transmembrane regions, and three extracellular loops. Anini's decoy GHS-R1a fusion protein, GHSR-Fc, has shown promise in inhibiting adiposity and weight gain in mice subjected to a high-fat diet.
Career Highlights
Throughout his career, Younes Anini has focused on the intersection of obesity research and therapeutic development. His innovative approaches have garnered attention in the scientific community, leading to advancements in understanding the role of ghrelin in weight regulation. His work has the potential to pave the way for new treatments targeting obesity and related health issues.
Collaborations
Younes Anini has collaborated with fellow researcher Qinghua Wang, contributing to the advancement of knowledge in the field of obesity treatment. Their combined efforts have led to significant insights and developments in understanding the mechanisms of ghrelin and its receptor.
Conclusion
Younes Anini's contributions to obesity treatment through his patented inventions highlight the importance of innovative research in addressing public health challenges. His work on ghrelin and its receptor offers promising avenues for therapeutic interventions, making a significant impact in the field of obesity research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile